The Nanotechnology in Medical Devices Market in the Asia Pacific is believed to be a USD 1211 Million market in 2019 and is anticipated to reach USD 2346 Million by the end of 2024 with a tremendous CAGR of 14.1% in the forecasted period.
The significant growth of the market since the last decade is attributed to the technology evolution, increasing the aging population and incidences of diseases. The nanotechnology in medicine is trusted to have a greater impact on the treatment, diagnosis, and prevention of diseases.
Nanotechnology in the medical devices deals with the repair at cellular level having dimensions that are minute fractions of human hair. Many applications of nanotechnology are in pipeline undergoing testing at various stages offering exciting opportunities. Nanotechnology is in its way of revolutionizing the way of treatment having the potentiality to save many lives in the future.
The nanotechnology-based medical devices market is driven by a host of factors that include increasing funding from government and rising facilities in research and development of nanotechnology, increasing the prevalence of aging population, rising awareness among the people, growing healthcare expenditure with the rising availability of insurance coverage and reimbursement.
However, the market also faces a few restraints that are affecting the growth which includes stringent regulatory policies and high costs involving nanotechnology in medical devices.
This research report segmented and sub-segmented into the following categories:
Regionally, Asia-Pacific market for Nanotechnology in Medical Devices is segmented into China, India, Japan, South Korea, Australia and the Rest of Asia Pacific. The Asia-Pacific market is the fastest-growing market for nanotechnology-based medical devices, mainly due to an increase in population, increased international research partnerships and increased R&D spending on nanotechnology. Moreover, major improvements in countries such as China, Taiwan, and India's healthcare infrastructure are further driving the market in all of these regions. China is leading the APAC market in terms of volume.
Next in the lead is Japan followed by India. Japan and India are expected to grow significantly over the forecast period due to factors such as increased career acceptance of sport and increased awareness of injuries. A growing aging population and a rising prevalence of cardiovascular diseases and diseases correlated with ribs, ears and other organs will create opportunities for the market in these developing nations. In addition, the high costs and time-consuming product approval processes for medical devices centered on nanotechnology that hinders market growth.
Companies playing an active role in the APAC Nanotechnology in Medical Devices Market are AMAG pharmaceuticals, Jude Medical, Inc., Smith & Nephew, Inc., PerkinElmer, Inc., Acusphere, Inc., 3M Company, Affymetrix, Inc., Starkey Hearing Technologies and Stryker Corporation.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Product
5.1.1 Implantable Material
5.1.1.1 Bone Restorative Material
5.1.1.2 Dental Filling Material
5.1.2active implantable material
5.1.2.1 Hearing Aid Devices
5.1.2.2 Cardio Rhythm Management Devices
5.1.3 Biochips
5.1.4 Medical Textile and Wound Dressing
5.1.5 Others
5.2 By Application
5.2.1 Diagnostics
5.2.2 Therapeutics
5.2.3 Research
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Acusphere, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 AMAG Pharmaceuticals
8.3 Stryker Corporation
8.4 3M Company
8.5 St. Jude Medical, Inc.
8.6 Affymetrix, Inc.
8.7 Smith & Nephew, Inc.
8.8 PerkinElmer, Inc.
8.9 Starkey Hearing Technologies
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
